Clinical Trial Update: Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial of NGX-4010 (capsaicin patch) for painful HIV-associated neuropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Peripheral Nervous System Diseases

Drugs mentioned

• NGX-4010 (capsaicin patch 8%)

Snippet

Sponsor: NeurogesX | Conditions: HIV Infections, Peripheral Nervous System Diseases | Phase 3 | Status: TERMINATED